- Home
- Industry Reports
- Biotechnology
- Healthcare
- Global Bioreactors Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Bioreactor refers to any manufactured or engineered device or system that supports a biologically active environment. The global bioreactors market will be growing at a CAGR of 6.8% to reach $1.71 Billion by 2025, from $1.2 Billion in 2019 during 2019-2025. The market growth can be attributed by growing popularity of single-use bioreactor among biopharmaceutical companies, increasing demand for personalised medicines and growing biopharmaceuticals and biologics industry. Despite these drivers, the major restraints hampering the market growth are the low capacity of single-use bioreactor and concerns regarding extractables. Emerging markets and technological advancements in the bioreactor are major opportunities of the bioreactors market.
Research Study Objectives:
- Define, estimate, and forecast the Bioreactors market statistics by cell, molecule, technology, material, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Bioreactors market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Bioreactors Market Analysis
- Analysis and conclusions on the future Bioreactors market outlook.
Top-down and bottom-up approaches are used to validate the Bioreactors Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Bioreactors Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Bioreactors market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Bioreactors market segmentation is as follows:
BY CELL
- Technological advancements in the bioreactor
- Bacterial cells
- Yeast cells
- Others
BY MOLECULE
- Vaccines
- Recombinant protein
- Stem cell
- Gene Therapy
- Others
BY TECHNOLOGY
- Wave-induced motion SUB
- Stirred SUB
- Stirred use bubble column
- Others
BY MATERIAL
- Glass
- Stainless steel
- Single use
BY APPLICATION
- Lab scale production
- Pilot scale production
- Full-scale production
BY END USER
- Research and development
- Biopharma manufacturers
- Contract manufacturing organisation’s
Geographical Analysis:
Bioreactors Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Bioreactors Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Bioreactors Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Bioreactors market players, such as
- Finesse Solutions, Inc.
- Applikon BiotechnologyV.
- PBS Biotech, Inc.
- Danaher Corporation
- Eppendorf AG
- Along with these companies, many other companies are considered in the report while analysing the Global Bioreactors competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing demand for personalised medicines
4.1.2. Rising orphan drugs developments
4.1.3. Rising biopharmaceuticals and biologics industry
4.1.4. Increase in incidences of lifestyle diseases such as diabetes and cancer
4.1.5. Growing popularity of single-use bioreactor among biopharmaceutical companies.
4.2. Market Restraints & Challenges
4.2.1. Concerns regarding extractable
4.2.2. Low capacity of single-use bioreactor
4.3. Market Opportunities
4.3.1. Emerging markets
4.3.2. Technological advancements in bioreactors
CHAPTER 5. GLOBAL BIOREACTORS MARKET – BY CELL
5.1. Bacterial cells
5.2. Yeast cells
5.3. Others
CHAPTER 6. GLOBAL BIOREACTORS MARKET – BY MOLECULE
6.1. Vaccines
6.2. Recombinant protein
6.3. Stem cell
6.4. Gene Therapy
6.5. Others
CHAPTER 7. GLOBAL BIOREACTORS MARKET – BY TECHNOLOGY
7.1. Wave-induced motion SUB
7.2. Stirred SUB
7.3. Stirred use bubble column
7.4. Others
CHAPTER 8. GLOBAL BIOREACTORS MARKET – BY MATERIAL
8.1. Glass
8.2. Stainless steel
8.3. Single use
CHAPTER 9. GLOBAL BIOREACTORS MARKET – BY APPLICATION
9.1. Lab scale production
9.2. Pilot scale production
9.3. Full-scale production
CHAPTER 10. GLOBAL BIOREACTORS MARKET – BY END USER
10.1. Research and development
10.2. Biopharma manufacturers
10.3. Contract manufacturing organisation’s
CHAPTER 11. GLOBAL BIOREACTORS MARKET – BY GEOGRAPHY
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Costa Rica
11.3. South America
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Chile
11.3.4. Columbia
11.3.5. Others
11.4. Europe
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Russia
11.4.7. Netherlands
11.4.8. Switzerland
11.4.9. Poland
11.4.10. Others
11.5. APAC
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. South Korea
11.5.5. Australia & New Zealand
11.5.6. Malaysia
11.5.7. Singapore
11.5.8. Others
11.6. Middle East & Africa
11.6.1. UAE
11.6.2. Saudi Arabia
11.6.3. Iran
11.6.4. Iraq
11.6.5. Qatar
11.6.6. South Africa
11.6.7. Algeria
11.6.8. Morocco
11.6.9. Nigeria
11.6.10. Egypt
11.6.11. Others
CHAPTER 12. GLOBAL BIOREACTORS MARKET – COMPANY PROFILES
12.1. Finesse Solutions, Inc.
12.2. Applikon Biotechnology B.V.
12.3. PBS Biotech, Inc.
12.4. Danaher Corporation
12.5. Eppendorf AG
12.6. Sartorius AG
12.7. ZETA Holding GmbH
12.8. Solaris Biotechnology srl
12.9. GE Healthcare
12.10. Pierre Guerin Technologies
12.11. Thermo Fisher Scientific Inc
12.12. Merck KGaA
12.13. CRB Consulting Engineers Inc.
12.14. Technip S.A.
12.15. Jacobs Engineering Group Inc.
CHAPTER 13. GLOBAL BIOREACTORS MARKET – COMPETITIVE LANDSCAPE
13.1. Market Share Analysis
13.2. Strategies adopted by top companies
13.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 14. MARKET INSIGHTS
14.1. Industry Experts Insights
14.2. Analysts Opinions
14.3. Investment Opportunities
CHAPTER 15. APPENDIX
15.1. List of Tables
15.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,511.39 - €7,534.18
- INR: ₹223,024.12 - ₹669,072.36
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,180.22 - £6,540.65
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Bioreactor refers to any manufactured or engineered device or system that supports a biologically active environment. The global bioreactors market will be growing at a CAGR of 6.8% to reach $1.71 Billion by 2025, from $1.2 Billion in 2019 during 2019-2025. The market growth can be attributed by growing popularity of single-use bioreactor among biopharmaceutical companies, increasing demand for personalised medicines and growing biopharmaceuticals and biologics industry. Despite these drivers, the major restraints hampering the market growth are the low capacity of single-use bioreactor and concerns regarding extractables. Emerging markets and technological advancements in the bioreactor are major opportunities of the bioreactors market.
Research Study Objectives:
- Define, estimate, and forecast the Bioreactors market statistics by cell, molecule, technology, material, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Bioreactors market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Bioreactors Market Analysis
- Analysis and conclusions on the future Bioreactors market outlook.
Top-down and bottom-up approaches are used to validate the Bioreactors Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Bioreactors Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Bioreactors market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Bioreactors market segmentation is as follows:
BY CELL
- Technological advancements in the bioreactor
- Bacterial cells
- Yeast cells
- Others
BY MOLECULE
- Vaccines
- Recombinant protein
- Stem cell
- Gene Therapy
- Others
BY TECHNOLOGY
- Wave-induced motion SUB
- Stirred SUB
- Stirred use bubble column
- Others
BY MATERIAL
- Glass
- Stainless steel
- Single use
BY APPLICATION
- Lab scale production
- Pilot scale production
- Full-scale production
BY END USER
- Research and development
- Biopharma manufacturers
- Contract manufacturing organisation’s
Geographical Analysis:
Bioreactors Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Bioreactors Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Bioreactors Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Bioreactors market players, such as
- Finesse Solutions, Inc.
- Applikon BiotechnologyV.
- PBS Biotech, Inc.
- Danaher Corporation
- Eppendorf AG
- Along with these companies, many other companies are considered in the report while analysing the Global Bioreactors competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing demand for personalised medicines
4.1.2. Rising orphan drugs developments
4.1.3. Rising biopharmaceuticals and biologics industry
4.1.4. Increase in incidences of lifestyle diseases such as diabetes and cancer
4.1.5. Growing popularity of single-use bioreactor among biopharmaceutical companies.
4.2. Market Restraints & Challenges
4.2.1. Concerns regarding extractable
4.2.2. Low capacity of single-use bioreactor
4.3. Market Opportunities
4.3.1. Emerging markets
4.3.2. Technological advancements in bioreactors
CHAPTER 5. GLOBAL BIOREACTORS MARKET – BY CELL
5.1. Bacterial cells
5.2. Yeast cells
5.3. Others
CHAPTER 6. GLOBAL BIOREACTORS MARKET – BY MOLECULE
6.1. Vaccines
6.2. Recombinant protein
6.3. Stem cell
6.4. Gene Therapy
6.5. Others
CHAPTER 7. GLOBAL BIOREACTORS MARKET – BY TECHNOLOGY
7.1. Wave-induced motion SUB
7.2. Stirred SUB
7.3. Stirred use bubble column
7.4. Others
CHAPTER 8. GLOBAL BIOREACTORS MARKET – BY MATERIAL
8.1. Glass
8.2. Stainless steel
8.3. Single use
CHAPTER 9. GLOBAL BIOREACTORS MARKET – BY APPLICATION
9.1. Lab scale production
9.2. Pilot scale production
9.3. Full-scale production
CHAPTER 10. GLOBAL BIOREACTORS MARKET – BY END USER
10.1. Research and development
10.2. Biopharma manufacturers
10.3. Contract manufacturing organisation’s
CHAPTER 11. GLOBAL BIOREACTORS MARKET – BY GEOGRAPHY
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Costa Rica
11.3. South America
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Chile
11.3.4. Columbia
11.3.5. Others
11.4. Europe
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Russia
11.4.7. Netherlands
11.4.8. Switzerland
11.4.9. Poland
11.4.10. Others
11.5. APAC
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. South Korea
11.5.5. Australia & New Zealand
11.5.6. Malaysia
11.5.7. Singapore
11.5.8. Others
11.6. Middle East & Africa
11.6.1. UAE
11.6.2. Saudi Arabia
11.6.3. Iran
11.6.4. Iraq
11.6.5. Qatar
11.6.6. South Africa
11.6.7. Algeria
11.6.8. Morocco
11.6.9. Nigeria
11.6.10. Egypt
11.6.11. Others
CHAPTER 12. GLOBAL BIOREACTORS MARKET – COMPANY PROFILES
12.1. Finesse Solutions, Inc.
12.2. Applikon Biotechnology B.V.
12.3. PBS Biotech, Inc.
12.4. Danaher Corporation
12.5. Eppendorf AG
12.6. Sartorius AG
12.7. ZETA Holding GmbH
12.8. Solaris Biotechnology srl
12.9. GE Healthcare
12.10. Pierre Guerin Technologies
12.11. Thermo Fisher Scientific Inc
12.12. Merck KGaA
12.13. CRB Consulting Engineers Inc.
12.14. Technip S.A.
12.15. Jacobs Engineering Group Inc.
CHAPTER 13. GLOBAL BIOREACTORS MARKET – COMPETITIVE LANDSCAPE
13.1. Market Share Analysis
13.2. Strategies adopted by top companies
13.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 14. MARKET INSIGHTS
14.1. Industry Experts Insights
14.2. Analysts Opinions
14.3. Investment Opportunities
CHAPTER 15. APPENDIX
15.1. List of Tables
15.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.